Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Sun W et al. | 2018 | intact cell/cell culture, human cell lines (Hela, HL60, OVCR3 and HT1080) | static magnetic field | - |
Surma SV et al. | 2014 | intact cell/cell culture, skeletal muscle satellite cells | static magnetic field | 60–400 µT |
Tanaka M et al. | 2010 | plant, <i>Phalaenopsis</i> | static magnetic field | 200 mT |
Tanasa E et al. | 2020 | intact cell/cell culture, 3T3-E1 cells (mouse osteoblast-like cell line) within silk-firboin scaffolds decorated with magnetic nanoparticles | static magnetic field, co-exposure, also other exposures without EMF | - |
Tang B et al. | 2020 | intact cell/cell culture, MC3T3-E1 cells (mouse osteoblast-like cell line), partly on ZnFe<sub>2</sub>O<sub>4</sub> coatings | static magnetic field, also other exposures without EMF, co-exposure | - |
Tang H et al. | 2019 | intact cell/cell culture, <i>Flavobacterium</i> sp. m1-14 | static magnetic field | - |
Tanioka N et al. | 1996 | intact cell/cell culture, B16C2 (murine melanoma cells) and EL-4 (murine T-lymphoma cells) | static magnetic field, MRI | 6.34 T |
Taskin M et al. | 2013 | bacterium, mold strains | static magnetic field, DC | 3–9 mT |
Tenuzzo B et al. | 2006 | intact cell/cell culture, human lymphocytes, mouse thymocytes, FRTL-5 cells (Fischer rat thyroid cells), Hep G2 cells (hepatic transformed cell line), HeLa cell line (human adenocarcinoma cell line), U937 (human leukemic monocyte cell line) and 3 DO cells (T cell hybridoma cell li | static magnetic field | 6 mT |
Tessaro LW et al. | 2015 | bacterium, <i>Staphylococcus epidermidis</i>, <i>Staphylococcus aureus</i>, <i>Serratia marcescens</i> and <i>Escherichia coli</i> | magnetic field, static magnetic field, low frequency | 2.1 µT–500 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.